12:00 AM
Dec 07, 2009
 |  BC Week In Review  |  Company News  |  Deals

DiaMedica, Sanomune deal

DiaMedica signed a non-binding letter of intent to acquire Sanomune in a stock deal. Sanomune will receive about 12.8 million common shares of DiaMedica valued at C$7.9 million (US$7.5 million) based on...

Read the full 138 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >